Net profit of Ishita Drugs & Industries remain constant at Rs 0.12 crore in the quarter ended December 2023 and also during the previous quarter ended December 2022. Sales declined 1.53% to Rs 3.21 crore in the quarter ended December 2023 as against Rs 3.26 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales3.213.26 -2 OPM %6.855.21 - PBDT0.190.19 0 PBT0.160.16 0 NP0.120.12 0 Powered by Capital Market - Live News

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News

Net profit of Ishita Drugs & Industries rose 75.00% to Rs 0.21 crore in the quarter ended September 2023 as against Rs 0.12 crore during the previous quarter ended September 2022. Sales rose 54.93% to Rs 4.40 crore in the quarter ended September 2023 as against Rs 2.84 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales4.402.84 55 OPM %4.774.93 - PBDT0.300.19 58 PBT0.270.16 69 NP0.210.12 75 Powered by Capital Market - Live News

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News

Ishita Drugs & Industries announced that the 30th Annual General Meeting (AGM) of the company will be held on 27 September 2023.Powered by Capital Market - Live News